|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2004-6-22
|
|
pubmed:abstractText |
The common treatment for antineutrophil cytoplasmic autoantibody (ANCA)-associated renal vasculitis is oral cyclophosphamide (CYC)-corticosteroid combination therapy. However, there are serious complications associated with long-term use of CYC. In this study, we investigate the efficacy of a purine synthesis inhibitor, mizoribine, for patients at high risk for relapse.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1523-6838
|
|
pubmed:author |
pubmed-author:HashimotoYukoY,
pubmed-author:HirayamaAkiA,
pubmed-author:HirayamaKouichiK,
pubmed-author:KobayashiMasakiM,
pubmed-author:KoyamaAkioA,
pubmed-author:NagaseSohjiS,
pubmed-author:NagataMichioM,
pubmed-author:ShimizuYoshioY,
pubmed-author:UsuiJoichiJ,
pubmed-author:YamagataKunihiroK,
pubmed-author:YohKeigyouK
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
44
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
57-63
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15211438-Aged,
pubmed-meshheading:15211438-Antibodies, Antineutrophil Cytoplasmic,
pubmed-meshheading:15211438-Biopsy,
pubmed-meshheading:15211438-Female,
pubmed-meshheading:15211438-Glomerulonephritis,
pubmed-meshheading:15211438-Humans,
pubmed-meshheading:15211438-Male,
pubmed-meshheading:15211438-Middle Aged,
pubmed-meshheading:15211438-Pilot Projects,
pubmed-meshheading:15211438-Purines,
pubmed-meshheading:15211438-Renal Circulation,
pubmed-meshheading:15211438-Ribonucleosides,
pubmed-meshheading:15211438-Treatment Outcome,
pubmed-meshheading:15211438-Vasculitis
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Treatment with the purine synthesis inhibitor mizoribine for ANCA-associated renal vasculitis.
|
|
pubmed:affiliation |
Majours of Medical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan. kidney@md.tsukuba.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
